AJMC® in the Press, March 1, 2019

An article from The American Journal of Managed Care^®’s sister site The Center for Biosimilars^® was highlighted by OBR Oncology’s daily newsfeed. The article, “Ahead of FDA Decision on its Pegfilgrastim Biosimilar, Sandoz Sues Amgen,” reported on Sandoz filing suit against Amgen, asking the United States District Court for the Northern District of California for a declaratory judgment of patent noninfringement and invalidity.